GCCA Joins BLOODPAC Consortium

We are proud to announce that the Global Colon Cancer Association is now a member of the Blood Profiling Atlas in Cancer (BLOODPAC) Consortium.

The BLOODPAC Consortium was established in February 2017 to accelerate the development, validation, and accessibility of liquid biopsy assays, ultimately improving outcomes for cancer patients. Through a pre-competitive collaborative infrastructure, BLOODPAC facilitates information sharing and consensus-building among key stakeholders across industry, academia, regulatory bodies, payers, and government agencies. Their commitment to addressing liquid biopsy disparities aligns with our mission to ensure equitable access to comprehensive colorectal cancer care, and we are eager to build this valuable partnership.